Medical AI Governance Market to Reach USD 1.9 Billion by 2035 at 21.7% CAGR: AI Safety, Regulatory Compliance & Responsible AI Driving Growth

 

Market Overview

According to MarketGenics, the global Medical AI Governance Market was valued at USD 0.3 billion in 2025 and is projected to reach USD 1.9 billion by 2035, expanding at a CAGR of 21.7%. The market is gaining momentum as healthcare organizations increasingly deploy AI for diagnosis, clinical decision support, medical devices, patient monitoring, and administrative applications. Growing concerns around AI safety, model validation, transparency, accountability, cybersecurity, data privacy, bias mitigation, and lifecycle management are increasing the need for structured medical AI governance solutions.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/medical-ai-governance-market-98622

Market Growth Drivers

Key growth drivers include the rapid adoption of AI and generative AI in healthcare, evolving regulatory and compliance requirements, and increasing demand for continuous AI performance monitoring. Healthcare organizations need governance frameworks capable of detecting model drift, performance degradation, bias, and reliability issues after deployment. The growing use of generative AI, LLMs, multimodal AI, and agentic AI is further increasing requirements for human oversight, explainability, auditability, risk management, and secure data handling. The regulatory compliance governance segment holds a major share of the market, accounting for approximately 28%, supported by growing requirements for documentation, validation, auditability, data protection, and post-market monitoring.

Key Players

The medical AI governance market is moderately fragmented, with competition centered on AI risk management, responsible AI, model monitoring, explainability, compliance automation, AI security, healthcare AI infrastructure, and lifecycle governance. According to MarketGenics, prominent players include Pacific AI, ALIGNMT AI, Amazon Web Services, Complira, Credo AI, Ferrum Health, Fiddler AI, Google, IBM, Microsoft, Newton’s Tree, Onboard AI, Signal 1, and Synergist Technology, among others.

Regional Insights

North America leads the global Medical AI Governance Market and is identified by MarketGenics as the most attractive region. Its leadership is supported by advanced healthcare AI adoption, established regulatory infrastructure, widespread deployment of AI-powered medical technologies, and strong investment in responsible AI and digital health. Asia Pacific is experiencing the highest growth, driven by healthcare digital transformation, increasing AI adoption, responsible-AI initiatives, interoperability requirements, and growing awareness of healthcare data governance. Europe is also witnessing strong growth, supported by increasingly stringent AI governance, transparency, risk-management, and compliance requirements.

Related Reports:

AI Agents Market

Penetration Testing as Service Market

AI-powered Analytics Market

Soil Conditioners Market

Peptide Stabilization Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co

Comments

Post a Comment

Popular posts from this blog

Fertilizers Market Size, Growth, Trends & Forecast 2026–2035

Image
  Market Overview The global Fertilizers Market was valued at approximately USD 279.9 billion in 2025 and is projected to reach USD 430.5 billion by 2035 , registering a CAGR of 4.4% during 2026–2035 . The market is driven by increasing global food demand, declining arable land, soil nutrient depletion, and the need to improve crop productivity. Nitrogenous fertilizers represent the largest product segment, while demand for specialty fertilizers, micronutrients, controlled-release fertilizers, bio-fertilizers, and enhanced-efficiency fertilizers is increasing as farmers focus on nutrient-use efficiency and sustainable agricultural practices. To obtain a free sample research report - https://marketgenics.co/download-report-sample/fertilizers-market-69005 Market Growth Drivers Rising population and growing food consumption are major factors supporting the Fertilizers Market . Farmers are increasingly required to improve crop yields from limited agricultural land, increasi...
Read more

Payment Orchestration Platform Market Outlook 2035: Opportunities Across North America, Europe & Asia-Pacific

Image
  Payment Orchestration Platform Market Overview According to MarketGenics Analysis , the global Payment Orchestration Platform Market is witnessing rapid growth, fueled by the expansion of digital commerce, increasing adoption of multi-payment ecosystems, and the growing need for secure, scalable, and optimized payment processing solutions. The market is estimated to be valued at USD 2.8 billion in 2025 and is projected to reach USD 10.8 billion by 2035 , registering a CAGR of 14.6% during the forecast period. Payment orchestration platforms provide businesses with a unified infrastructure to manage multiple payment gateways, payment service providers (PSPs), fraud detection tools, tokenization services, and cross-border payment methods through a single integration. These platforms enable intelligent payment routing, higher transaction success rates, lower operational costs, improved customer experiences, and enhanced regulatory compliance. The growing adoption of digital...
Read more

The Future of Rare Disease Treatment: Market Insights and Growth Analysis

Image
  Rare Disease Treatment Market (Global) Overview The market was valued at approximately USD 195–216 billion in 2024 and is projected to reach around USD 370+ billion by 2030 , growing at a CAGR of ~11–12% during the forecast period . The global rare disease treatment market is a fast-growing segment of the healthcare and biotechnology industry focused on therapies for conditions affecting very small patient populations. Although each disease impacts a limited number of individuals, collectively rare diseases represent a significant global healthcare burden. The market is expanding rapidly due to increasing genetic disorder detection, rising awareness, and strong regulatory incentives for orphan drug development . Advancements in biologics, gene therapies, and precision medicine are transforming treatment possibilities for previously untreatable conditions. Request a Free Sample Copy or View Report Summary: https://marketgenics.co/download-report-sample/rare-disease-trea...
Read more